Drugs / LOVAZA Omega 3-acid ethyl esters
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00791089 | Nov 2008 → Dec 2009 | atrial fibrillation | University of Michigan | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LOVAZA Omega 3-acid ethyl esters | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00791089 ↗ |